CV Sciences (CVSI) EBT Margin (2013 - 2026)
CV Sciences (CVSI) posted EBT Margin of 20.13% for Q1 2026, down 508.31% sequentially from 4.93% in Q4 2025, and down 1730.0% YoY from 1.23% in Q1 2025.
CV Sciences (CVSI) EBT Margin (2013 - 2026) Analysis & Trends
CV Sciences has reported EBT Margin for 14 years, with the latest figure at 20.13% in Q1 2026.
- Quarterly EBT Margin fell 1730.0% year-over-year to 20.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.39% (up 219.0% YoY) and the FY2025 annual result came in at 4.22%, up 941.0% from the prior year.
- EBT Margin declined to 20.13% in Q1 2026 per CVSI's latest filing, from 4.93% in the prior quarter.
- Over five years, EBT Margin peaked at 137.56% in Q1 2023 and troughed at 64.06% in Q2 2022.
- A 5-year average of 12.97% and a median of 14.77% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2024: EBT Margin soared 18512 bps in 2023, then tumbled 15310 bps in 2024.
- Over 5 years, EBT Margin stood at 61.05% in 2022, then jumped by 62 bps to 23.1% in 2023, then soared by 47 bps to 12.33% in 2024, then jumped by 140 bps to 4.93% in 2025, then slumped by 508 bps to 20.13% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 20.13%, 4.93%, and 11.73% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -25.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.80% |
| Mar 31, 2026 | -20.13% |
| Dec 31, 2025 | 4.93% |
| Sep 30, 2025 | -11.73% |
| Jun 30, 2025 | -7.21% |
| Mar 31, 2025 | -2.83% |
| Dec 31, 2024 | -12.33% |
| Sep 30, 2024 | -11.80% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | -15.54% |
| Dec 31, 2023 | -23.10% |
| Sep 30, 2023 | -10.93% |
| Jun 30, 2023 | -32.40% |
| Mar 31, 2023 | 137.56% |
| Dec 31, 2022 | -61.05% |
| Sep 30, 2022 | -27.49% |
| Jun 30, 2022 | -64.06% |
| Mar 31, 2022 | -47.56% |
| Dec 31, 2021 | -180.22% |
| Sep 30, 2021 | -0.78% |